Zafirlukast, a Cysteinyl Leukotriene Receptor 1 Antagonist, Reduces the Effect of Advanced Glycation End-Products in Rat Renal Mesangial Cells In Vitro

BACKGROUND: Zafirlukast is an antagonist of cysteinyl leukotriene receptor 1 (CysLTR1). Advanced glycation end-products (AGEs) are formed by the glycation of lipids and proteins in hyperglycemia, including diabetes mellitus. Zafirlukast has not previously been studied in diabetic nephropathy. This s...

Descripción completa

Detalles Bibliográficos
Autores principales: Yan, Liping, Sun, Ani, Xu, Xinwei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: International Scientific Literature, Inc. 2019
Materias:
Lab/In Vitro Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6880630/
https://www.ncbi.nlm.nih.gov/pubmed/31745068
http://dx.doi.org/10.12659/MSM.918187

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6880630/
https://www.ncbi.nlm.nih.gov/pubmed/31745068
http://dx.doi.org/10.12659/MSM.918187

Ejemplares similares